Clene Inc

-0.26 (-5.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)313.20M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.12 Million
Adjusted EPS-$0.17
See more estimates
10-Day MA$5.14
50-Day MA$5.76
200-Day MA$9.15
See more pivots

Clene Inc Stock, NASDAQ:CLNN

6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
United States of America
Phone: +1.801.676.9695
Number of Employees:


Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.